1990
DOI: 10.1016/0065-2571(90)90021-s
|View full text |Cite
|
Sign up to set email alerts
|

Regulation of the branched-chain α-ketoacid dehydrogenase and elucidation of a molecular basis for maple syrup urine disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
49
1

Year Published

1996
1996
2022
2022

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 73 publications
(50 citation statements)
references
References 47 publications
0
49
1
Order By: Relevance
“…), a transacylase, and a dehydrogenase (EC 1.8.1.4. ), and two regulatory enzymes, i.e., a specific kinase (EC 2.7.1.115) and a specific phosphatase, that regulate decarboxylase activity through a phosphorylation (inactive)/dephosphorylation (active) cycle (Harris et al, 1990). KIC, through inhibition of the kinase, activates the complex.…”
Section: Brain Glu Synthesis From Leu In Vivo 1305mentioning
confidence: 99%
“…), a transacylase, and a dehydrogenase (EC 1.8.1.4. ), and two regulatory enzymes, i.e., a specific kinase (EC 2.7.1.115) and a specific phosphatase, that regulate decarboxylase activity through a phosphorylation (inactive)/dephosphorylation (active) cycle (Harris et al, 1990). KIC, through inhibition of the kinase, activates the complex.…”
Section: Brain Glu Synthesis From Leu In Vivo 1305mentioning
confidence: 99%
“…It has been shown that insulin, glucocorticoid, thyroid hormone, and sex hormones regulate the activity and expression of BCKDK as well (17,20). In addition, the BCKDK activity is also subject to allosteric regulation by BCKAs, thiamine diphosphate, and other factors (7,21). BCKAs inhibit the BCKDK activity and attenuates its interaction with the BCKD complex.…”
mentioning
confidence: 99%
“…BCKDC catalyzes irreversible oxidative decarboxylation of the BCKAs to produce the branched chain acyl-CoAs and NADH and contains multiple copies of three enzymes: branched chain ␣-keto acid decarboxylase/dehydrogenase (E1), dihydrolipoyl transcylase (E2), and dihydrolipoamide dehydrogenase (E3) (8). BCKDC is inactivated by phosphorylation of the E1␣ subunit of the E1 enzyme, catalyzed by a specific kinase (BDK), which is inhibited by the ␣-keto acid of Leu (KIC, ␣-ketoisocaproate) (9,10).…”
mentioning
confidence: 99%